Propel Bio Management, LLC Portfolio Holdings
Propel Bio Management, LLC
- $82.4 Billion
- Q2 2025
Propel Bio Management, LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $82.4 Billion distributed in 16 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Plains Gp Holdings LP with a value of $24.7B, Achieve Life Sciences Inc with a value of $13.9B, Akero Therapeutics, Inc. with a value of $12.2B, Phathom Pharmaceuticals, Inc. with a value of $8.85B, and Abeona Therapeutics Inc. with a value of $5.53B.
Examining the 13F form we can see an decrease of $3.68B in the current position value, from $86.1B to 82.4B.
Propel Bio Management, LLC is based out at Los Angeles, CA
Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.